MedTrace Logo

Verification Study of the Effects of Consumption of the Test Food on the Musculoskeletal System

NCT07729657 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-07-27

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effects of the test products on the locomotor system in healthy Japanese adults with low muscle mass and knee joint discomfort. The main question it aims to answer is:

• Does the daily consumption of the test product improve subjective knee symptoms, quality of life (QOL), and physical function?

Participants will be asked to:

* Take 3 capsules of the test product daily for 12 weeks.
* Complete questionnaires regarding subjective knee symptoms and QOL.
* Undergo bilateral X-ray imaging.
* Undergo assessment of lower limb extension strength.
* Perform the stand-up test to evaluate lower limb muscle endurance.
* Perform the 10-meter walk test to evaluate walking ability.
* Undergo anthropometric and physical measurements. Researchers will compare Test Product 1, Test Product 2, and Test Product 3, against a placebo group to see if consumption of the study products improves knee symptoms, QOL, and physical function.

Conditions

  • Healthy Japanese Individuals

Interventions

DIETARY_SUPPLEMENT

Food containing NAG, HA, and PQQ

Take 3 capsules with water daily for 12 weeks.

DIETARY_SUPPLEMENT

Food containing NAG and HA

Take 3 capsules with water daily for 12 weeks.

DIETARY_SUPPLEMENT

Food containing NAG

Take 3 capsules with water daily for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Take 3 capsules with water daily for 12 weeks.

Sponsors & Collaborators

  • Orthomedico Inc.

    collaborator OTHER

  • WORSO.Co.,Ltd

    collaborator UNKNOWN

  • Bloomage Biotechnology Corp., Ltd.

    lead INDUSTRY

Principal Investigators

  • Tsuyoshi Takara, MD · Medical Corporation Seishinkai, Takara Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-30
Primary Completion
2026-12-14
Completion
2026-12-14

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07729657 on ClinicalTrials.gov